Fortrea Holdings Inc. is a leading global Contract Research Organization (CRO) specializing in comprehensive clinical development solutions for pharmaceutical, biotechnology, and medical device companies. With a strong legacy spanning over 30 years, the company has evolved from Covance and Labcorp Drug Development into an independent, innovation-driven clinical research organization focused on accelerating life-changing treatments for patients worldwide.
Fortrea provides end-to-end clinical trial and healthcare research services, helping sponsors streamline drug development processes with advanced scientific expertise, global operational capabilities, and technology-enabled solutions. The organization follows a patient-centric approach, emphasizing quality, transparency, innovation, and strategic collaboration to deliver exceptional clinical outcomes.
Its mission is to support biotech and biopharma companies in bringing safe, effective, and innovative therapies to market faster and more efficiently.
Company Information
Company Name: Fortrea Holdings Inc. Industry: Clinical Research / Biotechnology / Healthcare Services Company Type: Public Company Stock Exchange: NASDAQ (Ticker: FTRE) Founded: 2023 (Independent Company) Legacy Experience: 30+ Years Former Names: Covance → Labcorp Drug Development → Fortrea
Sign in with Google
